Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
46.16
+1.61 (3.61%)
At close: Feb 17, 2026, 4:00 PM EST
46.00
-0.16 (-0.35%)
Pre-market: Feb 18, 2026, 9:13 AM EST

Medline Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22
62,137---
Enterprise Value
77,790---
Debt / Equity Ratio
0.991.051.00-
Debt / EBITDA Ratio
4.955.197.11-
Debt / FCF Ratio
16.5012.0312.02-
Net Debt / Equity Ratio
0.931.030.90-
Net Debt / EBITDA Ratio
4.815.296.62-
Net Debt / FCF Ratio
15.5111.8310.82-
Asset Turnover
-0.71--
Inventory Turnover
-4.48--
Quick Ratio
1.691.432.18-
Current Ratio
3.663.394.13-
Return on Equity (ROE)
-7.29%--
Return on Assets (ROA)
-3.76%--
Return on Invested Capital (ROIC)
6.50%6.46%3.71%-
Return on Capital Employed (ROCE)
6.60%6.50%3.90%-
Payout Ratio
-126.50%48.72%-
Buyback Yield / Dilution
0.11%0.19%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q